Los puntos clave no están disponibles para este artículo en este momento.
The FDA is developing guidance on the use of “real-world evidence” — health care information from atypical sources, including electronic health records, billing databases, and product and disease registries — to assess the safety and effectiveness of drugs and devices.
Building similarity graph...
Analyzing shared references across papers
Loading...
Rachel E. Sherman
Steven A. Anderson
Gerald J. Dal Pan
New England Journal of Medicine
United States Food and Drug Administration
Center for Biologics Evaluation and Research
Center for Drug Evaluation and Research
Building similarity graph...
Analyzing shared references across papers
Loading...
Sherman et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d882b318b0ca7f91d18073 — DOI: https://doi.org/10.1056/nejmsb1609216
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: